Xiao-xiao Wang

Beijing Key Laboratory Of Hepatitis C And Immunotherapy For Liver Diseases
Beijing, 100044, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Endothelial cells expressing CPE and vWF are involved in the Immunopathogenesis of primary biliary cholangitis.

Endothelial cells expressing CPE and vWF are involved in the Immunopathogenesis of primary biliary cholangitis.

Journal: Scientific reports
Published: April 06, 2025

Pyroptosis Plays a Key Role Through Macrophages in Primary Biliary Cholangitis of Mice.

Pyroptosis Plays a Key Role Through Macrophages in Primary Biliary Cholangitis of Mice.

Journal: BioMed research international
Published: March 27, 2025

Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence.

Hepatic Steatosis Analysis in Metabolic Dysfunction-Associated Steatotic Liver Disease Based on Artificial Intelligence.

Journal: Diagnostics (Basel, Switzerland)
Published: November 10, 2024

Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells.

Exploring the Pathogenesis of Autoimmune Liver Diseases from the Heterogeneity of Target Cells.

Journal: Journal of clinical and translational hepatology
Published: November 26, 2023

Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models.

Collagen co-localized with macrovesicular steatosis better differentiates fibrosis progression in non-alcoholic fatty liver disease mouse models.

Journal: Frontiers in medicine
Published: February 23, 2023

Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients.

Treatment of ursodeoxycholic acid with glucocorticoids and immunosuppressants may improve the long-term survival rate in primary biliary cholangitis patients.

Journal: Medicine
Published: November 19, 2022

The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019.

The burden of hepatitis C virus in the world, China, India, and the United States from 1990 to 2019.

Journal: Frontiers in public health
Published: September 10, 2022

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis.

Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis.

Journal: Frontiers in medicine
Published: April 21, 2022

Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients.

Direct antiviral agents upregulate natural killer cell potential activity in chronic hepatitis C patients.

Journal: Clinical and experimental medicine
Published: December 23, 2018

qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.

qFIBS: An Automated Technique for Quantitative Evaluation of Fibrosis, Inflammation, Ballooning, and Steatosis in Patients With Nonalcoholic Steatohepatitis.

Journal: Hepatology (Baltimore, Md.)
Published: November 01, 2018

Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir.

Recovery of natural killer cells is mainly in post-treatment period in chronic hepatitis C patients treated with sofosbuvir plus ledipasvir.

Journal: World journal of gastroenterology
Published: July 27, 2018

HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.

HBsAg stimulates NKG2D receptor expression on natural killer cells and inhibits hepatitis C virus replication.

Journal: Hepatobiliary & pancreatic diseases international : HBPD INT
Published: May 24, 2017
Showing 1-12 of 12

Last Updated: 09/26/2026